Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 6
1993 6
1994 3
1995 11
1996 7
1997 11
1998 17
1999 10
2000 12
2001 14
2002 26
2003 19
2004 21
2005 21
2006 15
2007 17
2008 18
2009 20
2010 23
2011 19
2012 20
2013 28
2014 39
2015 33
2016 27
2017 40
2018 30
2019 25
2020 18
2021 28
2022 24
2023 23
2024 21
2025 20
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

624 results

Results by year

Filters applied: . Clear all
Page 1
Hepatocellular carcinoma.
Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Llovet JM, et al. Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18. Nat Rev Dis Primers. 2016. PMID: 27158749 Free article. Review.
Boceprevir.
Rizza SA, Talwani R, Nehra V, Temesgen Z. Rizza SA, et al. Drugs Today (Barc). 2011 Oct;47(10):743-51. doi: 10.1358/dot.2011.47.10.1656503. Drugs Today (Barc). 2011. PMID: 22076489 Review.
Boceprevir is a hepatitis C virus (HCV) serine protease NS3 inhibitor that has recently been approved by the U.S. ...
Boceprevir is a hepatitis C virus (HCV) serine protease NS3 inhibitor that has recently been approved by the U.S. ...
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.
Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Tschöpe C, et al. Nat Rev Cardiol. 2021 Mar;18(3):169-193. doi: 10.1038/s41569-020-00435-x. Epub 2020 Oct 12. Nat Rev Cardiol. 2021. PMID: 33046850 Free PMC article. Review.
Cryoglobulinaemia.
Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C. Roccatello D, et al. Nat Rev Dis Primers. 2018 Aug 2;4(1):11. doi: 10.1038/s41572-018-0009-4. Nat Rev Dis Primers. 2018. PMID: 30072738 Free article. Review.
Many lymphoproliferative, infectious and autoimmune disorders have been associated with mixed cryoglobulinaemia; however, hepatitis C virus (HCV) is the aetiologic agent in most patients. The underlying mechanism of the disorder is B cell lymphoproliferation and aut …
Many lymphoproliferative, infectious and autoimmune disorders have been associated with mixed cryoglobulinaemia; however, hepatitis …
A global view of hepatocellular carcinoma: trends, risk, prevention and management.
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. Yang JD, et al. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22. Nat Rev Gastroenterol Hepatol. 2019. PMID: 31439937 Free PMC article. Review.
Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol addiction, metabolic liver disease (particularly nonalcoholic fatty liver disease) and exposure to dietary toxins such as aflatoxins and aristolochic acid. ...
Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol addiction, metabolic liver disease (particularly non …
Infection, immunity, and cancer.
Persing DH, Prendergast FG. Persing DH, et al. Arch Pathol Lab Med. 1999 Nov;123(11):1015-22. doi: 10.5858/1999-123-1015-IIAC. Arch Pathol Lab Med. 1999. PMID: 10539899 Free article. Review.
Viral arthritis.
Ytterberg SR. Ytterberg SR. Curr Opin Rheumatol. 1999 Jul;11(4):275-80. doi: 10.1097/00002281-199907000-00009. Curr Opin Rheumatol. 1999. PMID: 10411381 Review.
Studies of rheumatic syndromes associated with other viral infections, including alphaviruses, rubella, hepatitis C, and retroviruses, suggest differing mechanisms of host interaction with the infectious agents to cause disease....
Studies of rheumatic syndromes associated with other viral infections, including alphaviruses, rubella, hepatitis C, and retro …
Epidemiology of Marginal Zone Lymphoma.
Cerhan JR, Habermann TM. Cerhan JR, et al. Ann Lymphoma. 2021 Mar;5:1. doi: 10.21037/aol-20-28. Epub 2021 Mar 30. Ann Lymphoma. 2021. PMID: 33829216 Free PMC article.
Established risk factors for MZL (or MZL subtypes) include family history of NHL, genetic loci in the HLA region, Helicobacter pylori infection (gastric MALT lymphoma), and several autoimmune diseases (Sjogren syndrome, systemic lupus erythematosus and Hashimoto thyroiditis), wit …
Established risk factors for MZL (or MZL subtypes) include family history of NHL, genetic loci in the HLA region, Helicobacter pylori infect …
Symptomatic cryoglobulinemia.
Dispenzieri A. Dispenzieri A. Curr Treat Options Oncol. 2000 Jun;1(2):105-18. doi: 10.1007/s11864-000-0055-4. Curr Treat Options Oncol. 2000. PMID: 12057048 Review.
First line treatment for symptomatic, essential type II or type III cryoglobulinemia associated with hepatitis C should include interferon (IFN)-alpha. Depending on the severity of clinical presentation, adjuvant corticosteroids or plasmapheresis should be considere …
First line treatment for symptomatic, essential type II or type III cryoglobulinemia associated with hepatitis C should includ …
Hepatic inflammation and progressive liver fibrosis in chronic liver disease.
Czaja AJ. Czaja AJ. World J Gastroenterol. 2014 Mar 14;20(10):2515-32. doi: 10.3748/wjg.v20.i10.2515. World J Gastroenterol. 2014. PMID: 24627588 Free PMC article. Review.
The fibrotic mechanisms associated with liver inflammation have been clarified, and anti-fibrotic agents promise to improve outcomes as adjunctive therapies. Hepatitis C virus and immune-mediated responses can activate hepatic stellate cells by increasing oxidative …
The fibrotic mechanisms associated with liver inflammation have been clarified, and anti-fibrotic agents promise to improve outcomes as adju …
624 results